Should we stop offering indium-111 octreotide scans in favour of gallium-68 PET-CT scans in the UK?
Department of Nuclear Medicine, Royal Liverpool University Hospital, Liverpool, UK.
Neena
N
Kalsy
Sobhan
S
Vinjamuri
D005188:False Negative Reactions; D005710:Gallium Radioisotopes; D006801:Humans; D018358:Neuroendocrine Tumors / Q000000981:diagnostic imaging* / Q000378:metabolism; D015282:Octreotide / Q000031:analogs & derivatives*; D000072078:Positron Emission Tomography Computed Tomography / Q000379:methods* / Q000706:statistics & numerical data; D019275:Radiopharmaceuticals; D017481:Receptors, Somatostatin / Q000378:metabolism; D012680:Sensitivity and Specificity; D006113:United Kingdom
D005710:Gallium Radioisotopes; D019275:Radiopharmaceuticals; D017481:Receptors, Somatostatin; C094279:indium-111-octreotide; D015282:Octreotide